Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196815 | 0.77 | — | — | |
| SCHEMBL12589581 | 0.77 | CA12 (0.59) | CA12CA1CA2CA9GAA | |
| SCHEMBL31286385 | 0.76 | CA12 (0.46) | CA12CA1CA2CA9GAA | |
| Iodide SCHEMBL30042709 | 0.75 | CA12 (0.57) | CA12CA1CA2CA9GAA | |
| SCHEMBL8632964 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL8143027 | 0.75 | CA12 (0.57) | CA12CA1CA2CA9GAA | |
| Hydrochloric Acid SCHEMBL1876862 | 0.75 | CA12 (0.57) | CA12CA1CA2CA9GAA | |
| SCHEMBL65107 | 0.74 | CA12 (0.61) | CA12CA1CA2CA9GAA | |
| SCHEMBL288560 | 0.73 | — | — | |
| SCHEMBL8912516 | 0.73 | CA12 (0.55) | CA12CA1CA2CA9GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119498254-A | Construction method and application of spontaneous tumor model of mouse gastric cancer | 北京肿瘤医院(北京大学肿瘤医院) | 2025-02-25 | — | — | CN | claimed |
| CN-109374224-B | Acetylene gas color development leak detection device | 浙江省海洋水产养殖研究所 | 2020-05-22 | — | — | CN | claimed |
| CN-119498254-A | Construction method and application of spontaneous tumor model of mouse gastric cancer | 北京肿瘤医院(北京大学肿瘤医院) | 2025-02-25 | — | — | CN | disclosed |
| CN-108452079-B | Methods and compositions for delaying senescence, inhibiting tumor cell growth, and improving microcirculation | 江西天元药业有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-107929420-B | Traditional Chinese medicine composition for improving qi and blood functions and immunity of human body and detection method | 江西天元药业有限公司 | 2021-01-19 | — | — | CN | disclosed |
| CN-109374224-B | Acetylene gas color development leak detection device | 浙江省海洋水产养殖研究所 | 2020-05-22 | — | — | CN | disclosed |
| CN-109374224-A | A kind of acetylene gas colour developing leakage detection apparatus | 浙江省海洋水产养殖研究所 | 2019-02-22 | — | — | CN | disclosed |
| CN-102526649-A | Actinolite pill integrative new formulation preparation technology and production method thereof | SUZHOU ZHIWEITANG BIOTECH CO | 2012-07-04 | — | — | CN | disclosed |
| CN-102058566-A | Dry powder inhaler with constituent rubescensin A as well as preparation method and application thereof | UNIV CHINA PHARMA | 2011-05-18 | — | — | CN | disclosed |
| US-20080311189-A1 | Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer | IBET - INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA (PT) | 2008-12-18 | — | — | US | disclosed |
| CN-1316922-C | Anti-fatigue health food and preparation method thereof | KUNMING TIANBAO TECHNOLOGY DEV (CN) | 2007-05-23 | — | — | CN | disclosed |
| EP-1737874-A1 | COMPOSITIONS COMPRISING ORGANOMETALLIC MOLYBDENUM COMPOUNDS FOR TREATING CANCER | Instituto de Biologia Experimental e Tecnologia (IBET) (PT) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005087783-A1 | COMPOSITIONS COMPRISING ORGANOMETALLIC MOLYBDENUM COMPOUNDS FOR TREATING CANCER | IBET-INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA (PT) | 2005-09-22 | — | — | WO | disclosed |
| CN-1666655-A | Anti-fatigue health food and preparation method thereof | KUNMING TIANBAO TECHNOLOGY DEV (CN) | 2005-09-14 | — | — | CN | disclosed |
| US-20030207800-A1 | Proteins, polynucleotides encoding them and methods of using the same | CURAGEN CORPORATION | 2003-11-06 | — | — | US | disclosed |
| WO-2002066643-A2 | PROTEINS, POLYNUCLEOTIDES ENCODING THEM AND METHODS OF USING THE SAME | CURAGEN CORPORATION (US) | 2002-08-29 | — | — | WO | disclosed |
| US-3996004-A | MEASURING NITRATE AND NITRITE COMPOUND CONTENT IN A SAMPLE | THERMO ELECTRON CORPORATION (US) | 1976-12-07 | — | — | US | disclosed |
| US-3996003-A | MEASURING THE N-NITROSO COMPOUND CONTENT OF A SAMPLE | THERMO ELECTRON CORPORATION (US) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311189-A1 | Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer | HCCS, MCL1, IDH1 | CA12 1734/4885CA1 2241/4885CA2 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.